Story

Worthington Soars on Earnings Beat, TriSalus Jumps on FDA Clearance in After-Hours Trading

ENTHMSVIIDZHZH-TWJAKOHI
Sep 22, 20262 min read
Worthington Soars on Earnings Beat, TriSalus Jumps on FDA Clearance in After-Hours Trading

Summary

Worthington Enterprises surged over 14% on strong quarterly results and TriSalus Life Sciences jumped 28% after receiving FDA clearance, while InnovAge Holding Corp. fell on news of a secondary stock offering.

Text size
Background

Several companies saw significant price moves in after-hours trading, driven by catalysts including a strong earnings report, a key regulatory approval, and a planned secondary stock offering.

Earnings and Sector Strength

Worthington Enterprises (WOR) surged 14% in extended trading after the company reported strong financial results for its fiscal first quarter. The building products manufacturer announced:

  • Adjusted earnings per share (EPS) of $0.82, beating analyst estimates by $0.07.
  • Net sales of $343.89 million, an increase of 13.2% year-over-year.

The company attributed the performance to volume growth in its Consumer Products and Building Products segments.

Homebuilder KB Home (KBH) rose 2% post-market. The move was linked to positive read-throughs from the broader housing sector and signs of firming buyer demand, with investors focused on new order rates and gross margin stability amid a shifting interest rate environment.

Sample IUX Markets – In-articleAd

Biotech and Tech Catalysts

TriSalus Life Sciences (TLSI) saw its shares jump 28% after the company announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its TriNav® Advance device. This clearance expands its Pressure-Enabled Drug Delivery™ (PEDD) portfolio, designed to help interventional radiologists treat solid tumors in smaller, more distal blood vessels.

Quantum computing firm IonQ (IONQ) climbed 8% following the announcement of a technical achievement in quantum error correction. The company said it demonstrated an end-to-end, real-time quantum error correction decoder that can operate on a single standard CPU, a development aimed at removing processing bottlenecks that can stall quantum computing workloads.

Secondary Offering Weighs on InnovAge

InnovAge Holding Corp. (INNV) shares dropped 12% following the announcement of an underwritten secondary public offering of 10,000,000 shares of its common stock. The shares are being sold by funds affiliated with Apax Partners and Welsh, Carson, Anderson & Stowe. The offering creates a potential overhang on the stock, as underwriters have a 30-day option to purchase up to an additional 1,500,000 shares.

Read next

More on Stocks
Back to latest news

LATEST